<DOC>
	<DOCNO>NCT02419781</DOCNO>
	<brief_summary>The aim study clarify efficacy endovascular treatment acute ischemic stroke patient large vessel occlusion respond intravenous recombinant tissue plasminogen activator ( rt-PA ) therapy .</brief_summary>
	<brief_title>Recovery Endovascular Salvage Cerebral Ultra-acute Embolism ( RESCUE ) -Japan RCT</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<criteria>Acute ischemic stroke patient treat intravenous rtPA therapy within 4.5 hour onset persistent occlusion IC M1 proximal portion* confirm cerebral angiography . * : M1 proximal portion mean segment MCA within 5mm internal carotid bifurcation . Patients receive endovascular treatment within 8 hour onset . Patients whose DWIASPECTS 5 point , CTASPECT 6 point cerebral angiography . Patients whose NIHSS 8 29 point . Patients 20 85 year . Gender matter . Consent study participant must obtain patient legal representative writing . Patients whose neurological symptom improve NIHSS eight point less intravenous rtPA therapy . Patients whose mRS 3 point onset . 3 ) Patients past history lumbar puncture arterial puncture difficult hemostasis . Patients intracranial tumor Patients hypersensitivity contrast agent . Patients serious renal disease . Patients malignant tumor . Patients pregnancy suspect pregnancy , lactation . Patients finding acute myocardial infarction pericarditis myocardial infarction . Patients follow 3 month . Patients past history cerebral aneurysm , cerebral arteriovenous malformation , cerebral venous thrombosis , moyamoya disease . Patients occlusion besides ICA M1 proximal portion . Patients aortic dissection complicate endovascular treatment . Patients tortuous artery prevent navigation device target vessel . Patients consider inappropriate participate study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>